Effect of Infliximab and Adalimumab on Experimental Colitis Following Orally Supplemented Iron

Background: Orally administered iron can induce colonic inflammation in healthy animals and aggravate experimental colitis. Aim: To investigate the influence of the biologic agents infliximab and adalimumab on the severity of TNBS colitis following orally supplemented iron. Materials-Methods: 204 Wi...

Full description

Bibliographic Details

Published in:	Journal of Investigative Surgery
Main Authors:	John Triantafillidis, Costas Vagianos, George Agrogiannis, Aristofanis Gikas, Georgia Douvi, Nikolaos Syrmos, Efstratios Patsouris, Apostolos Papalois
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-01-01
Subjects:	experimental colitis ulcerative colitis crohn's disease inflammatory bowel disease iron anemia infliximab adalimumab biologic agents
Online Access:	http://dx.doi.org/10.1080/08941939.2016.1215574